|
Volumn 53, Issue 2, 2009, Pages
|
Aliskiren therapy will have minimal effect on intracellular renin of renin-producing cells.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALISKIREN;
AMIDE;
ANGIOTENSINOGEN;
ANTIHYPERTENSIVE AGENT;
FORSKOLIN;
FUMARIC ACID DERIVATIVE;
RENIN;
ANIMAL;
BLOOD;
DOSE RESPONSE;
DRUG EFFECT;
GENETICS;
HUMAN;
JUXTAGLOMERULAR APPARATUS;
MAST CELL;
MAST CELL LEUKEMIA;
METABOLISM;
NOTE;
PATHOLOGY;
RAT;
SPRAGUE DAWLEY RAT;
TRANSGENIC RAT;
TUMOR CELL LINE;
AMIDES;
ANGIOTENSINOGEN;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FORSKOLIN;
FUMARATES;
HUMANS;
JUXTAGLOMERULAR APPARATUS;
LEUKEMIA, MAST-CELL;
MAST CELLS;
RATS;
RATS, SPRAGUE-DAWLEY;
RATS, TRANSGENIC;
RENIN;
MLCS;
MLOWN;
|
EID: 59849101131
PISSN: None
EISSN: 15244563
Source Type: Journal
DOI: 10.1161/hypertensionaha.108.126722 Document Type: Note |
Times cited : (3)
|
References (0)
|